
Pharmacists React to Medicare's Proposed Changes for 2015 Drug Plans
PRESS RELEASE
ALEXANDRIA, Va. (Jan. 7, 2014) —
“While we are still reviewing the proposed rule, we have some initial observations.
“First, we are encouraged by CMS’ response to
“Second, we appreciate CMS’ efforts to address concerns over maximum allowable cost (MAC) pricing, particularly in the wake of
“Third, we strongly support CMS’ move away from co-pay arrangements that incentivize the use of mail order over retail. Research utilizing Medicare’s own data
“In addition, we commend CMS for proposing to expand coverage of medication therapy management (MTM) services. And we thank the agency for recommending a prohibition on reimbursement methods, such as pro-rated dispensing fees, that
“For years NCPA members, staff and patients have raised these and other issues for CMS’ attention. We appreciate the steps that the agency is taking to address these concerns. We look forward to continuing to work with the CMS and other policymakers to preserve these proposals in the final 2015 regulations to be issued later this year.”
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.














































































































































































































